Knight Therapeutics (GUD.TO) Q1 2025 Earnings

20MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.04
0.01
0.06
0.11

Details

Expected EPS
0.017797677184773
Actual EPS
0.10947517141
Surprise EPS
0.09
Surprise Percent
+515.11%

Description

Knight Therapeutics (GUD.TO) has reported earnings of 0.10947517141 per share for Q1 2025.

0 Comments

Share your thoughts